These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 26815601)

  • 1. Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis.
    Tektonidou MG; Dasgupta A; Ward MM
    Arthritis Rheumatol; 2016 Jun; 68(6):1432-41. PubMed ID: 26815601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995.
    Ward MM
    Arch Intern Med; 2000 Nov; 160(20):3136-40. PubMed ID: 11074743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to renal transplantation among patients with end-stage renal disease due to lupus nephritis.
    Ward MM
    Am J Kidney Dis; 2000 May; 35(5):915-22. PubMed ID: 10793027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation.
    Swai J; Zhao X; Noube JR; Ming G
    BMC Nephrol; 2020 May; 21(1):156. PubMed ID: 32357924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis.
    Ward MM
    Kidney Int; 2000 May; 57(5):2136-43. PubMed ID: 10792635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis.
    Ward MM
    Am J Kidney Dis; 2000 Sep; 36(3):516-25. PubMed ID: 10977783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic status and the incidence of ESRD.
    Ward MM
    Am J Kidney Dis; 2008 Apr; 51(4):563-72. PubMed ID: 18371532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of biopsy-proven lupus nephritis in Iran.
    Fatemi A; Kazemi M; Sayedbonakdar Z; Farajzadegan Z; Karimzadeh H; Moosavi M
    Int J Rheum Dis; 2013 Dec; 16(6):739-46. PubMed ID: 24267776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
    Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
    Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
    Hiraki LT; Lu B; Alexander SR; Shaykevich T; Alarcón GS; Solomon DH; Winkelmayer WC; Costenbader KH
    Arthritis Rheum; 2011 Jul; 63(7):1988-97. PubMed ID: 21445963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis.
    Moon SJ; Park HS; Kwok SK; Ju JH; Kim HY; Park SH
    Clin Exp Rheumatol; 2013; 31(1):31-9. PubMed ID: 22935632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes.
    Haring CM; Rietveld A; van den Brand JA; Berden JH
    J Am Soc Nephrol; 2012 Jan; 23(1):149-54. PubMed ID: 22034639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking.
    Ward MM; Studenski S
    Arch Intern Med; 1992 Oct; 152(10):2082-8. PubMed ID: 1417382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Zhang L; Lee G; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Kidney Int; 2016 Jun; 89(6):1337-45. PubMed ID: 27165824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death.
    Arriens C; Chen S; Karp DR; Saxena R; Sambandam K; Chakravarty E; James JA; Merrill JT
    Clin Immunol; 2017 Dec; 185():3-9. PubMed ID: 27923701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
    Takada K; Arefayene M; Desta Z; Yarboro CH; Boumpas DT; Balow JE; Flockhart DA; Illei GG
    Arthritis Rheum; 2004 Jul; 50(7):2202-10. PubMed ID: 15248218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry.
    Norby GE; Mjøen G; Bjørneklett R; Vikse BE; Holdaas H; Svarstad E; Aasarød K
    Lupus; 2017 Jul; 26(8):881-885. PubMed ID: 28059018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five consecutive years' study of renal function outcome among biopsy proven lupus nephritis patients in Southern Iran.
    Pakfetrat M; Malekmakan L; Kamranpour M; Tadayon T
    Lupus; 2017 Sep; 26(10):1082-1088. PubMed ID: 28420065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.
    Faurschou M; Starklint H; Halberg P; Jacobsen S
    J Rheumatol; 2006 Aug; 33(8):1563-9. PubMed ID: 16881113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.